Kenneth S. Abramowitz is a Managing General Partner and co-founder of NGN Capital, a $250 million worldwide healthcare venture capital fund. He joined NGN from The Carlyle Group in New York where he was Managing Director from 2001 to 2003, focused on U.S. buyout opportunities in the healthcare industry. Prior to joining Carlyle, Mr. Abramowitz worked as an Analyst at Sanford C. Bernstein & Co. where he covered the medical-supply, hospital-management and HMO industries for 23 years.
Mr. Abramowitz has published several notable studies on healthcare service companies, major medical mergers and cardiovascular device innovation, among others. Mr. Abramowitz earned a B.A. from Columbia University in 1972 and an M.B.A. from Harvard Business School in 1976. Mr. Abramowitz currently sits on the Board of Directors of EKOS Corp., OptiScan Biomedical Corp., Valtech Ltd., and Small Bone Innovations, Inc.
1. Jerusalem has been the capital city of the Jewish people (but no one else) for 3,000 years, including both ancient Israel and current Israel. There...
Israel's cabinet on Sunday approved a plan to build a defense compound on the site of the recently demolished premises of the United Nations Relief and Works Agency in East...
The relationship between Israel and Somaliland has rapidly evolved into a strategic partnership spanning security, energy, infrastructure, and economic cooperation,...
Israel and Lebanon agreed to a 45-day extension of a ceasefire that has tamped down the conflict between Israel and Iran-backed terrorist group Hezbollah in southern Lebanon, as two days of talks facilitated...
Kenneth S. Abramowitz
